Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 30;26(7):3202.
doi: 10.3390/ijms26073202.

Synthesis, Characterization, and Preliminary In Vitro Anticancer Activity of Zinc Complexes Containing Amino Acid-Derived Imidazolium-Based Dicarboxylate Ligands

Affiliations

Synthesis, Characterization, and Preliminary In Vitro Anticancer Activity of Zinc Complexes Containing Amino Acid-Derived Imidazolium-Based Dicarboxylate Ligands

Carlos J Carrasco et al. Int J Mol Sci. .

Abstract

Coordination polymers containing zinc and imidazolium-based dicarboxylate ligands, [LR]-, were synthesized by reacting zinc acetate with HLR compounds, 1. The resulting complexes were characterized and structurally identified using single-crystal X-ray diffraction, revealing polymeric structures for the complexes [Zn(LR)2]n (R = Gly, 2a; βAla, 2b) and [Zn(LLeu)2(H2O)2]n (2c). In these structures, the [LR]- ligands adopt a bridging monodentate μ-κ1-O11-O3 coordination mode, resulting in distorted tetrahedral (2a, 2b) or octahedral (2c) geometries around the zinc center. When the synthesis was carried out in the presence of amino acids, mixed ligand complexes [Zn(LR)(aa)(H2O)]n (R = aa = Val, 2d, and R = aa = Ile, 2e) were formed. Complexes 2d-2e were also structurally characterized using single-crystal X-ray crystallography, revealing that the ligand [LR]- maintained the same coordination mode, while the zinc center adopted a five-coordinated geometry. The cytotoxic activity of complexes 2a-2e was evaluated against three cancer cell lines and one non-cancerous cell line. Remarkably, these complexes exhibited higher toxicity against cancer cells than against the non-cancerous cell line, and they showed greater selectivity than carboplatin, a commonly used chemotherapy drug. Although, in general, these complexes did not surpass the selectivity of gemcitabine, complex 2c stood out for exhibiting a selectivity index value similar to that of gemcitabine against melanoma cells. Among the series, compounds 2a-2c demonstrated the highest activity, with 2a being the only complex with some selective activity against lung cancer. Complex 2b was the most active, though with low selectivity, while complex 2c exhibited the highest selectivity for melanoma and bladder cancer (selectivity index of 3.0).

Keywords: X-ray; amino acid; anticancer; imidazolium-dicarboxylate; selectivity; zinc.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Scheme 1
Scheme 1
Synthesis of complexes 2a2c (in EtOH/H2O at 70 °C for 1 h).
Scheme 2
Scheme 2
Synthesis of complexes 2d and 2e (in EtOH/H2O at 70 °C for 1 h).
Figure 1
Figure 1
1D coordination polymer of complex 2b aligned along the b axis with ellipsoids of the ORTEP representation displayed with 50% probability.
Figure 2
Figure 2
(a) ORTEP representation of the asymmetric unit of 2c, with ellipsoids displayed with 50% probability. (b) Polymeric 2c growth showing the octahedral coordination of zinc.
Figure 3
Figure 3
ORTEP representation of asymmetric units of 2d (a) and 2e (b), with ellipsoids displayed with 50% probability.
Figure 4
Figure 4
Effect of complexes 2, carboplatin and gemcitabine, on the viability of human non-malignant cells (HaCaT) and human cancer cells (A549, MeWo, and T24). The cells were exposed to reagents for 72 h, and cell viability was measured using the resazurin assay. Data represent mean ± SEM from at least three independent experiments. For statistical analysis, the t-test (paired, two-tailed) was used. * p < 0.05, ** p < 0.01, and *** p <0.001 (similar representations for marks + or #).

Similar articles

References

    1. Bruijnincx P.C., Sadler P.J. New Trends for Metal Complexes with Anticancer Activity. Curr. Opin. Chem. Biol. 2008;12:197–206. doi: 10.1016/j.cbpa.2007.11.013. - DOI - PMC - PubMed
    1. Ott I. On the Medicinal Chemistry of Gold Complexes as Anticancer Drugs. Coord. Chem. Rev. 2009;253:1670–1681. doi: 10.1016/j.ccr.2009.02.019. - DOI
    1. Ndagi U., Mhlongo N., Soliman M.E. Metal Complexes in Cancer Therapy—An Update from Drug Design Perspective. Drug Des. Dev. Ther. 2017;11:599–616. doi: 10.2147/DDDT.S119488. - DOI - PMC - PubMed
    1. Hindi K.M., Panzner M.J., Tessier C.A., Cannon C.L., Youngs W.J. The Medicinal Applications of Imidazolium Carbene-Metal Complexes. Chem. Rev. 2009;109:3859–3884. doi: 10.1021/cr800500u. - DOI - PMC - PubMed
    1. Santini C., Pellei M., Gandin V., Porchia M., Tisato F., Marzano C. Advances in Copper Complexes as Anticancer Agents. Chem. Rev. 2014;114:815–862. doi: 10.1021/cr400135x. - DOI - PubMed

LinkOut - more resources